More Business Wire
View Older Stories View Newer Stories-
Business Park Sofia Appoints Jordan Krastev as Chief Commercial Officer and Managing Director
-
Business Park Sofia Appoints Konstantin Pavlov as Chief Financial Officer
-
Amid Cost Of Living Crisis, UK Consumers Look To Shake Up How They Access And Use Credit
-
LiveWire® Opens European Reservations for S2 Del Mar® and Confirms Pricing and Delivery Schedule
-
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
-
RE: Aubit International (in official liquidation) (the “Company”)
-
First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer
-
Tineco Floor One S7 Steam, the 3-in-1 Smart Cordless Steam Floor Washer
-
Tineco Presents the FLOOR ONE S7 Steam - the 3-in-1 Cleaning Device for the Household
-
United States: TotalEnergies Joins Forces With Corio and Rise to Develop 3+ GW Wind Project Offshore New York & New Jersey
-
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
-
Genialis and Cancer Research Horizons Collaborate to Develop AI-Driven Patient Classifiers
-
ADOCIA’s Partner Tonghua Dongbao Announces Positive Results of Three Clinical Trials on BioChaperone® Combo
-
Mind Your Money: 5 Tips From Pocket Money Card nimbl to Spot and Stop Online Fraud
-
CYBERIA Announces first Akamai DDoS Scrubbing Center in Saudi Arabia
-
National Football League Teams Up with SES for Game Content Distribution
-
Tineco Unveils the Floor One S7 Steam, Its New Intelligent Vacuum Cleaner to Sanitize All the Rooms in Your Home
-
Celltrion, Inc. & Celltrion Healthcare Co., Ltd. Announce Shareholders Approval of Merger
-
Alphawave Semi Announces Appointment of Rahul Mathur as Chief Financial Officer
-
Nidec Announces Financial Results for Fiscal Second Quarter and Six Months Ended September 30, 2023
-
Nidec Announces Differences between Projected and Actual Financial Results for First-Half FY2023
-
ENHERTU® Approved in the EU as the First HER2 Directed Therapy for Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer
-
MaxLinear’s URX Open Source Platform and prpl Foundation’s prplOS Drive Innovation in Home Connectivity at prpl Summit 2023
-
EH Group tests HTPEM Fuel Cell to decarbonise aviation
-
Bias in AI Computer Vision Systems Dramatically Reduced with Synthetic Data ‘Digital Humans’
-
CARMAT Presented Its Progress on the EFICAS Clinical Study at the 36th Journées de La Pitié in Paris
-
SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US
-
Azelis Reinforces Its Footprint in the EMEA Flavors & Fragrances Market With the Acquisition of BLH
-
APO’s Newest Member Turkiye Hosts 64th Workshop Meeting of Heads of National Productivity Organizations
-
Teen Cosmetic Company, Prom Queen, takes Center Stage on Macys.com
-
Covation Holdings Continues Expansion in Asia Pacific With New Regional Corporate Headquarters
-
Berkshire Hathaway Specialty Insurance Names Sami Jaghbir as Underwriting Manager in Queensland
-
Celltrion USA Announces U.S. FDA Approval of ZYMFENTRA® (infliximab-dyyb), the First and Only Subcutaneous infliximab, for the Treatment of People With Inflammatory Bowel Disease
-
Marqeta Study: Even Satisfied Credit Cardholders Are Shopping For Their Next Card, Seeking Tailored Rewards and Embedded Finance Experiences
-
Updated Data from CIRCULATE-Japan Presented at ESMO 2023 Reinforces Signatera’s Prognostic and Predictive Value in Analysis of 2,500+ Colorectal Cancer Patients
-
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
-
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Reduced Risk of Death by More Than Half Versus Chemotherapy in Patients With Previously Untreated Locally Advanced or Metastatic Urot
-
Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Lin
-
Unit21 Launches Real-Time Monitoring to Fight Real-Time Fraud
-
Datopotamab deruxtecan plus IMFINZI® (durvalumab) demonstrated robust and durable tumor responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA Phase Ib/I
-
Raludotatug Deruxtecan Continues to Demonstrate Promising Clinical Activity in Patients with Advanced Ovarian Cancer in Early Trial
-
Datopotamab Deruxtecan Plus Durvalumab Demonstrated Robust and Durable Tumor Responses in First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer in BEGONIA Phase 1b/2 Trial
-
Detailed Results from Phase 3 CABINET Pivotal Trial Evaluating Cabozantinib in Advanced Neuroendocrine Tumors Presented at ESMO 2023
-
Faraday Future to Deliver FF 91 2.0 Futurist Alliance to World Champion Race Car Driver Justin Bell on October 24
-
Metropolitan Issues Statement on Death of San Fernando City Councilwoman Cindy Montañez
-
SME Launches Training and Electric Vehicle Certification to Address High and Unmet Demand for Electrification Skills
-
AeroDef Manufacturing 2023 Exhibitor Preview: Aerospace and Defense Global Suppliers, Distributors and Equipment Builders to Demonstrate Innovative Technologies and Solutions for Sector Manufacturers
-
University of Phoenix Vice President of Analytics, Avinash Tripathi, Speaks at CDAO Summit in Boston
-
Merck’s WELIREG® (belzutifan) Significantly Improved Progression-Free Survival and Objective Response Rates Versus Everolimus in Certain Previously Treated Patients With Advanced Renal Cell Carcino
-
CHNT Group Showed at The 24th Conference on The Electric Power Supply Industry
